Urinary incontinence future or investigational therapies: Difference between revisions
No edit summary |
Kiran Singh (talk | contribs) |
||
| Line 13: | Line 13: | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Urology]] | [[Category:Urology]] | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 14:10, 16 June 2015
|
Urinary incontinence Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Urinary incontinence future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Urinary incontinence future or investigational therapies |
|
FDA on Urinary incontinence future or investigational therapies |
|
CDC on Urinary incontinence future or investigational therapies |
|
Urinary incontinence future or investigational therapies in the news |
|
Blogs on Urinary incontinence future or investigational therapies |
|
Risk calculators and risk factors for Urinary incontinence future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Future or Investigational Therapies
There are trials taking place in the UK at the moment using Botox. It has been tested with some success under general anesthetic conditions, and is currently (February 2006) being tried under local anesthetic. While it originally appears that it may be quite successful for women, it does not appear to be as successful for men. Botox works for around 6-9 months when the treatment has to be redone.